search
Back to results

Maintaining Fitness During Neo-adjuvant Chemotherapy for Oesophago-gastric Cancer: a Feasibility Study (ChemoFit)

Primary Purpose

Esophageal Adenocarcinoma, Gastric Adenocarcinoma

Status
Unknown status
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
ChemoFit exercise prehabilitation intervention
Sponsored by
Newcastle-upon-Tyne Hospitals NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Esophageal Adenocarcinoma

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Operable adenocarcinoma of the oesophagus, oesophago-gastric junction and stomach (locally advanced adenocarcinoma with planned preoperative chemotherapy, T3+, T1/2 N+)
  • Planned preoperative chemotherapy with ECX, ECX variant or FLOT chemotherapy
  • Age >18
  • Ability to complete CPET
  • Ability to consent to study and carry out the planned intervention.

Exclusion Criteria:

  • Standard contraindications to CPET testing as defined by ATS Guidance
  • Orthopaedic limitations to CPET and / or daily exercise, for example, amputation, severe knee or hip disease.
  • Inoperable cancer at initial screening MDT
  • Planned non-surgical treatment with either radiotherapy or combined chemoradiotherapy

Sites / Locations

  • Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation TrustRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

ChemoFit exercise prehabilitation intervention

Arm Description

Exercise intervention consisting of walking and increasing daily step count. This is monitored by wearing a pedometer device. Other part of intervention are 5 simple strengthening exercises.

Outcomes

Primary Outcome Measures

Recruitment rate
Defined as the proportion of all patients approached that agree to enter the study.
Completion rate
Defined as the proportion of all patients that enter the study that remain participants at the end of the defined study period (at surgery).
Individual compliance
With the intervention, defined as the percentage of intervention days when the patient was wearing his/her pedometer, was contactable every week and was recording his/her daily step count.

Secondary Outcome Measures

CPET measurements
Cardiopulmonary fitness measured by cardiopulmonary exercise testing.
Sarcopenia
Change in amount of L3 level skeletal muscle area
Sarcopenia
Change in grip strength
Step count
Change in daily step count from pedometer each day
Quality of life
Quality of life using QLQ-C30 and QLQ-OG25 questionnaires
End of study questionnaire
Subjective perception of intervention using questionnaire
Focus group
End of study 'PPI' focus group to assess exercise intervention
Outcome of oncology treatment
Percentage of planned chemotherapy delivered
Outcome of oncology treatment
Number of patients with dose reductions or who terminate chemotherapy early
Outcome of oncology treatment
Admissions to hospital with chemotherapy induced toxicity

Full Information

First Posted
October 1, 2019
Last Updated
March 11, 2020
Sponsor
Newcastle-upon-Tyne Hospitals NHS Trust
Collaborators
Newcastle University
search

1. Study Identification

Unique Protocol Identification Number
NCT04194463
Brief Title
Maintaining Fitness During Neo-adjuvant Chemotherapy for Oesophago-gastric Cancer: a Feasibility Study
Acronym
ChemoFit
Official Title
Maintaining Fitness During Neo-adjuvant Chemotherapy for Oesophago-gastric Cancer: a Feasibility Study to Design and Investigate the Utility of a Simple, Home-Based, Exercise Intervention During Chemotherapy. (ChemoFit)
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Unknown status
Study Start Date
February 28, 2019 (Actual)
Primary Completion Date
June 30, 2020 (Anticipated)
Study Completion Date
June 30, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Newcastle-upon-Tyne Hospitals NHS Trust
Collaborators
Newcastle University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Feasibility study to investigate the utility of a simple, home-based, exercise intervention during and after neo-adjuvant chemotherapy but prior to surgery for esophageal and gastric adenocarcinoma.
Detailed Description
The principle aim of this study is to test the feasibility of utilising a home-based 'prehabilitation' exercise regimen in oesophago-gastric patients during preoperative chemotherapy and the period leading up to surgical resection. The investigators also hope to explore secondary outcomes of such a regimen, such as maintenance of fitness, the incidence of sarcopenia, muscle function and the outcomes of therapy. The investigators will explore the added value of blood-borne frailty biomarkers to objectively measure changes in physiology during neo-adjuvant chemotherapy (NAC). This will be tested using CPET, CT measured sarcopenia, grip strength and a small panel of biomarkers as secondary outcome and exploratory measures. Thus the main question is: 'Will patients participate in a home-based exercise programme during and after NAC for oesophago-gastric cancer?'

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Esophageal Adenocarcinoma, Gastric Adenocarcinoma

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
ChemoFit exercise prehabilitation intervention
Arm Type
Experimental
Arm Description
Exercise intervention consisting of walking and increasing daily step count. This is monitored by wearing a pedometer device. Other part of intervention are 5 simple strengthening exercises.
Intervention Type
Other
Intervention Name(s)
ChemoFit exercise prehabilitation intervention
Intervention Description
Exercise intervention consists of walking monitored by wearing a pedometer device. After a baseline measurement of participant's walking activity is done, increase in step count from baseline step count is prescribed. This increase in step count is achieved by walking or jogging at moderate intensity for a target of 30 minutes per day, each day. Participants are also encouraged to perform other physical if they wish and are able to. Patients are regularly contacted by a member of the research team on a weekly basis and given an option to maintain or to increase their step count further. The same approach is used after each week of the intervention. Strengthening exercises will form a further part of the exercise intervention. They are performed every day, 7 days a week. Patients are supplied with resistance bands with handles. They are educated on how to perform two repetitions of 5 simple exercises, each for 1 minute duration.
Primary Outcome Measure Information:
Title
Recruitment rate
Description
Defined as the proportion of all patients approached that agree to enter the study.
Time Frame
1 year
Title
Completion rate
Description
Defined as the proportion of all patients that enter the study that remain participants at the end of the defined study period (at surgery).
Time Frame
1 year
Title
Individual compliance
Description
With the intervention, defined as the percentage of intervention days when the patient was wearing his/her pedometer, was contactable every week and was recording his/her daily step count.
Time Frame
1 year
Secondary Outcome Measure Information:
Title
CPET measurements
Description
Cardiopulmonary fitness measured by cardiopulmonary exercise testing.
Time Frame
1 year
Title
Sarcopenia
Description
Change in amount of L3 level skeletal muscle area
Time Frame
1 year
Title
Sarcopenia
Description
Change in grip strength
Time Frame
1 year
Title
Step count
Description
Change in daily step count from pedometer each day
Time Frame
1 year
Title
Quality of life
Description
Quality of life using QLQ-C30 and QLQ-OG25 questionnaires
Time Frame
1 year
Title
End of study questionnaire
Description
Subjective perception of intervention using questionnaire
Time Frame
1 year
Title
Focus group
Description
End of study 'PPI' focus group to assess exercise intervention
Time Frame
1 year
Title
Outcome of oncology treatment
Description
Percentage of planned chemotherapy delivered
Time Frame
1 year
Title
Outcome of oncology treatment
Description
Number of patients with dose reductions or who terminate chemotherapy early
Time Frame
1 year
Title
Outcome of oncology treatment
Description
Admissions to hospital with chemotherapy induced toxicity
Time Frame
1 year
Other Pre-specified Outcome Measures:
Title
Exploratory outcome measures
Description
Circulating biomarkers that measure frailty and immune function
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Operable adenocarcinoma of the oesophagus, oesophago-gastric junction and stomach (locally advanced adenocarcinoma with planned preoperative chemotherapy, T3+, T1/2 N+) Planned preoperative chemotherapy with ECX, ECX variant or FLOT chemotherapy Age >18 Ability to complete CPET Ability to consent to study and carry out the planned intervention. Exclusion Criteria: Standard contraindications to CPET testing as defined by ATS Guidance Orthopaedic limitations to CPET and / or daily exercise, for example, amputation, severe knee or hip disease. Inoperable cancer at initial screening MDT Planned non-surgical treatment with either radiotherapy or combined chemoradiotherapy
Facility Information:
Facility Name
Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust
City
Newcastle Upon Tyne
State/Province
Tyne And Wear
ZIP/Postal Code
NE1 4LP
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rhona Sinclair
Phone
0191 2336161
Email
rhona.sinclair@nuth.nhs.uk
First Name & Middle Initial & Last Name & Degree
Jakub Chmelo
Email
jakub.chmelo@nuth.nhs.uk
First Name & Middle Initial & Last Name & Degree
Rhona Sinclair

12. IPD Sharing Statement

Citations:
PubMed Identifier
36137639
Citation
Cooper M, Chmelo J, Sinclair RCF, Charman S, Hallsworth K, Welford J, Phillips AW, Greystoke A, Avery L. Exploring factors influencing uptake and adherence to a home-based prehabilitation physical activity and exercise intervention for patients undergoing chemotherapy before major surgery (ChemoFit): a qualitative study. BMJ Open. 2022 Sep 22;12(9):e062526. doi: 10.1136/bmjopen-2022-062526.
Results Reference
derived
PubMed Identifier
35945625
Citation
Chmelo J, Phillips AW, Greystoke A, Charman SJ, Avery L, Hallsworth K, Welford J, Cooper M, Sinclair RCF. A feasibility trial of prehabilitation before oesophagogastric cancer surgery using a multi-component home-based exercise programme: the ChemoFit study. Pilot Feasibility Stud. 2022 Aug 9;8(1):173. doi: 10.1186/s40814-022-01137-6.
Results Reference
derived
PubMed Identifier
32346484
Citation
Chmelo J, Phillips AW, Greystoke A, Charman SJ, Avery L, Hallsworth K, Welford J, Sinclair RCF. A feasibility study to investigate the utility of a home-based exercise intervention during and after neo-adjuvant chemotherapy for oesophago-gastric cancer-the ChemoFit study protocol. Pilot Feasibility Stud. 2020 Apr 23;6:50. doi: 10.1186/s40814-020-00597-y. eCollection 2020.
Results Reference
derived

Learn more about this trial

Maintaining Fitness During Neo-adjuvant Chemotherapy for Oesophago-gastric Cancer: a Feasibility Study

We'll reach out to this number within 24 hrs